Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients With Advanced or Metastatic Urothelial Carcinoma (516-003)

  • Details

ClinicalTrials.gov ID: NCT03606174
Diagnosis Type: NA
USOR Number: 18033

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NA
USOR Number: 17140

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating The Efficacy and Safety of Neo-adjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (GO40241)

  • Details

ClinicalTrials.gov ID: NCT03456063
Diagnosis Type: NSCLC
USOR Number: 17140

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma (UTX-TGR-205)

  • Details

ClinicalTrials.gov ID: NCT02793583
Diagnosis Type: Non-Hodgkins
USOR Number: 16065

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

C16038: An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (Phase IV)

  • Details

ClinicalTrials.gov ID: NCT03173092
Diagnosis Type: NA
USOR Number: 17081

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304

  • Details

ClinicalTrials.gov ID: NCT02656303
Diagnosis Type: CLL
USOR Number: 16213

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase II single-arm trial to investigate tepotinib in advanced (Stage IIIB/IV) non-small cell lung cancer with MET exon 14 (METex14) skipping alterations or MET amplification (VISION): MS200095-0022

  • Details

ClinicalTrials.gov ID: NCT02864992
Diagnosis Type: NSCLC
USOR Number: 16006

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Hematologic

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry (M07-001)

  • Details

ClinicalTrials.gov ID: NCT01374360
Diagnosis Type: NA
USOR Number: 08160

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (D8220R00004)

  • Details

ClinicalTrials.gov ID: NCT03816683
Diagnosis Type: NA
USOR Number: 18127

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, Colorado 80113
43.15 mi. away
P: (303) 740-8200

More Details View Practice Page

Pages